Movano logo

MovanoNASDAQ: MOVE

Profile

Sector:

Healthcare

Country:

United States

IPO:

23 March 2021

Next earnings report:

14 November 2024

Last dividends:

N/A

Next dividends:

N/A
$24.08 M
-82%vs. 3y high
26%vs. sector
-vs. 3y high
-vs. sector
-89%vs. 3y high
49%vs. sector
-vs. 3y high
-vs. sector

Price

pre-market | 8 min ago
$3.65+$0.03(+0.83%)

Dividend

No data over the past 3 years
$1.50 M$500.00 K

Analysts recommendations

Institutional Ownership

MOVE Latest News

Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
prnewswire.com04 November 2024 Sentiment: -

Company Continues to Work with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif. , Nov. 4, 2024 /PRNewswire/ -- Movano Health  (Nasdaq:  MOVE ) (the "Company") provided an update on an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split.

Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'Amelio
prnewswire.com30 October 2024 Sentiment: POSITIVE

Collaboration Will Expand Awareness of Movano's Female First Wearable to D'Amelio's 12 Million Social Media Followers PLEASANTON, Calif. , Oct. 30, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) today announced its first brand partnership with digital creator, wife, mom and entrepreneur Heidi D'Amelio.

Movano Health Announces Reverse Stock Split
prnewswire.com25 October 2024 Sentiment: NEGATIVE

Shares Expected to Begin Trading on Split-Adjusted Basis on October 29, 2024 PLEASANTON, Calif. , Oct. 25, 2024 /PRNewswire/ --  Movano Health  (Nasdaq: MOVE) announced today that it will implement a 1-for-15 reverse stock split of the issued shares of its common stock (the "Reverse Stock Split"), effective at 12:01 a.m.

Movano Health Provides Update on FDA Review of EvieMED Ring
prnewswire.com10 October 2024 Sentiment: POSITIVE

The Company continues to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Oct. 10, 2024 /PRNewswire/ -- Movano Health  (Nasdaq: MOVE) announced today that the Company recently received additional clarifying questions from the FDA related to medical aspects of the EvieMED Ring, as part of the final phase of the Company's 510(k) application review process.

Evie, Movano Health's Smart Ring for Women, is Back In Stock with Key Upgrades
prnewswire.com17 September 2024 Sentiment: POSITIVE

Orders Reopen with Enhancements to AI Powered Health Insights, Sleep and Heart Rate Measurements and More PLEASANTON, Calif. , Sept. 17, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) today announced the immediate availability of its Evie Ring , the first smart ring designed specifically for women.

Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring
prnewswire.com03 September 2024 Sentiment: POSITIVE

Following the positive outcome of a recent agency meeting, the Company will continue to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Sept. 3, 2024 /PRNewswire/ --  Movano Health  (Nasdaq: MOVE) announced today that a productive in-person meeting with the FDA on August 15, 2024, resulted in a positive outcome regarding the EvieMED Ring's wellness features and metrics.

Movano Health Reports Q2 2024 Financial Results and Provides Business Update
prnewswire.com14 August 2024 Sentiment: POSITIVE

Prepares for September 17, 2024, Evie Ring back in stock date Announces brand partnership with digital creator Heidi D'Amelio Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. , Aug. 14, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported second quarter 2024 results and provided a business update.

Movano Health Provides Progress Update on EvieMED Regulatory Filing
prnewswire.com05 August 2024 Sentiment: POSITIVE

Company continues to work with FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Aug. 5, 2024 /PRNewswire/ --  Movano Health  (Nasdaq:  MOVE ) plans to meet with the FDA in mid-August, as part of the Company's ongoing process to secure a 510(k) clearance for the EvieMED Ring, a wearable designed to not only provide medical device functionality through its pulse oximetry feature, but also offer numerous wellness metrics related to sleep, activity and mood/energy/symptom logging.

Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event
prnewswire.com28 June 2024 Sentiment: POSITIVE

Allele Capitals' Matt Hughes will moderate future forward panel on enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif. , June 28, 2024 /PRNewswire/ -- Movano Health  (Nasdaq: MOVE) announced the addition of two expert participants to its B2B: The Next Wearables Boom Virtual Event to be held on July 11 – Dr. Fatima Rodriguez and Matt Hughes.

Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion
prnewswire.com13 June 2024 Sentiment: POSITIVE

Enhancements address significant clinical enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif., June 13, 2024 /PRNewswire/ -- Movano Health  (Nasdaq:  MOVE ) announced major advances in the accuracy of its heart rate in motion algorithm following the implementation of deep learning into the processing.

What type of business is Movano?

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.

What sector is Movano in?

Movano is in the Healthcare sector

What industry is Movano in?

Movano is in the Medical Devices industry

What country is Movano from?

Movano is headquartered in United States

When did Movano go public?

Movano initial public offering (IPO) was on 23 March 2021

What is Movano website?

https://movano.com

Is Movano in the S&P 500?

No, Movano is not included in the S&P 500 index

Is Movano in the NASDAQ 100?

No, Movano is not included in the NASDAQ 100 index

Is Movano in the Dow Jones?

No, Movano is not included in the Dow Jones index

When was Movano the previous earnings report?

No data

When does Movano earnings report?

The next expected earnings date for Movano is 14 November 2024